We are live on ! Find out more
VWM

Vigilare Wealth Management Portfolio holdings

AUM $326M
1-Year Est. Return 21.58%
This Fund
S&P 500
This Quarter Est. Return
+5.75%
1 Year Est. Return
+21.58%
3 Year Est. Return
+56.88%
5 Year Est. Return
+49.16%
10 Year Est. Return
–
AUM
$141M
AUM Growth
+$35.2M
Cap. Flow
+$32.8M
Cap. Flow %
23.33%
Top 10 Hldgs %
28.13%
Holding
216
New
67
Increased
82
Reduced
37
Closed
20

Top Buys

Rank Stock Value
1
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$3.31M
2
AMLP icon
Alerian MLP ETF
AMLP
+$2.82M
3
PBW icon
Invesco WilderHill Clean Energy ETF
PBW
+$1.86M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$1.55M
5
AMZN icon
Amazon
AMZN
+$1.26M

Top Sells

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$2.08M
2
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.34M
3
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$1.12M
4
SH icon
ProShares Short S&P500
SH
+$899K
5
GSY icon
Invesco Ultra Short Duration ETF
GSY
+$853K

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Healthcare 10.89%
3 Consumer Discretionary 10.41%
4 Communication Services 7.29%
5 Consumer Staples 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FATE icon
201
Fate Therapeutics
FATE
$326M
– –
-2,395
Closed -$218K
FOLD
202
DELISTED
Amicus Therapeutics
FOLD
– –
-9,100
Closed -$210K
IGIB icon
203
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
– –
-5,887
Closed -$364K
IGSB icon
204
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
– –
-11,830
Closed -$653K
KMB icon
205
Kimberly-Clark
KMB
$36.5B
– –
-1,580
Closed -$213K
KPTI icon
206
Karyopharm Therapeutics
KPTI
$48M
– –
-1,281
Closed -$297K
NBIX icon
207
Neurocrine Biosciences
NBIX
$16.6B
– –
-2,170
Closed -$208K
PBP icon
208
Invesco S&P 500 BuyWrite ETF
PBP
$362M
– –
-11,174
Closed -$229K
RPG icon
209
Invesco S&P 500 Pure Growth ETF
RPG
$2.09B
– –
-6,540
Closed -$213K
SH icon
210
ProShares Short S&P500
SH
$897M
– –
-12,500
Closed -$899K
SRPT icon
211
Sarepta Therapeutics
SRPT
$1.77B
– –
-1,240
Closed -$211K
VCIT icon
212
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
– –
-2,059
Closed -$200K
VEEV icon
213
Veeva Systems
VEEV
$37.4B
– –
-916
Closed -$249K
ZYME icon
214
Zymeworks
ZYME
$1.67B
– –
-4,675
Closed -$221K
CLVS
215
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-32,200
Closed -$155K
GWPH
216
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-1,850
Closed -$214K
5 6 7 8
9

Similar funds

DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
ECH
ER Collective Holdings Washington, District of Columbia $326M AUM
AFA
Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return
BCM
Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return
ISFAN
Investor's Fiduciary Advisor Network Snoqualmie, Washington $326M AUM 19.7% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
CWM
Chesapeake Wealth Management Williamsburg, Virginia $326M AUM 17.8% 1-Year Est. Return

Vigilare Wealth Management's Q1 2021 Portfolio in Review

As of Q1 2021, Vigilare Wealth Management held 216 positions worth $141M, up 33% from $106M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Vigilare Wealth Management deployed $32.8M of net new capital in Q1 2021, opening 67 new positions and adding to 82 existing holdings. Its largest new stake was Alerian MLP ETF: 96,485 shares worth $2.94M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $2.08M trimmed.

  • Vigilare Wealth Management's largest Q1 2021 buy was Alerian MLP ETF: 96,485 shares worth $2.94M.
  • Vigilare Wealth Management added most to Invesco S&P 500 Equal Weight ETF in Q1 2021, an estimated $3.31M increase.
  • Vigilare Wealth Management's biggest Q1 2021 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $2.08M.
  • Vigilare Wealth Management fully exited ProShares Short S&P500 in Q1 2021, selling an estimated $899K.
  • Vigilare Wealth Management's ten largest holdings make up 28% of its $141M portfolio in Q1 2021.
  • Vigilare Wealth Management opened 67 new positions and closed 20 in Q1 2021.
  • Vigilare Wealth Management's portfolio value rose 33% quarter-over-quarter to $141M.

Based on Vigilare Wealth Management's 13F filing for Q1 2021, filed 29 Apr 2021.